Science · 2011 · 180 citations · 8 references
Life SciencesEndocrinologyMolecular BiologyCell SignalingDiabetologySignal TransductionDiabetes MellitusDiabetes Mellitus BiochemistryGlucose HomeostasisHypoglycemia DisordersHypoglycemia ManagementInsulin Signaling In MetabolismActivating MutationsGenetic Causes Of HypoglycemiaHypoglycemia In DiabetesInsulin Signal TransductionInsulin SignalingInsulin Signaling PathwayMutation
Pathological fasting hypoglycemia in humans is usually explained by excessive circulating insulin or insulin-like molecules or by inborn errors of metabolism impairing liver glucose production. We studied three unrelated children with unexplained, recurrent, and severe fasting hypoglycemia and asymmetrical growth. All were found to carry the same de novo mutation, p.Glu17Lys, in the serine/threonine kinase AKT2, in two cases as heterozygotes and in one case in mosaic form. In heterologous cells, the mutant AKT2 was constitutively recruited to the plasma membrane, leading to insulin-independent activation of downstream signaling. Thus, systemic metabolic disease can result from constitutive, cell-autonomous activation of signaling pathways normally controlled by insulin.
8
Han Cho, James Mu, Jason K. Kim et al. · Science · 2001 · 1.8K citations
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten, Andrew L. Faber, Candice L. Horn et al. · Nature · 2007 · 1.3K citations
Mathieu Firmann, Vladimir Mayor, Pedro Marques‐Vidal et al. · BMC Cardiovascular Disorders · 2008 · 742 citations · Full text
A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in <i>AKT2</i>
Stella George, Justin J. Rochford, Christian Wolfrum et al. · Science · 2004 · 557 citations · Full text